<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-09T19:53:40Z</responseDate>
  <request identifier="oai:figshare.com:article/34048961" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34048961</identifier>
        <datestamp>2026-10-01T17:40:37Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_811</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_10_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Univariable and multivariable analyses of DFS.&lt;/p&gt;</dc:title>
          <dc:creator>Haitao Huang (182705)</dc:creator>
          <dc:creator>Lili Feng (154280)</dc:creator>
          <dc:creator>Min-Er Zhong (6758177)</dc:creator>
          <dc:creator>Huifen Ye (11271543)</dc:creator>
          <dc:creator>Zhenhui Li (282794)</dc:creator>
          <dc:creator>Su Yao (3627038)</dc:creator>
          <dc:creator>Yunrui Ye (13909343)</dc:creator>
          <dc:creator>Yulin Liu (457083)</dc:creator>
          <dc:creator>Minning Zhao (13909337)</dc:creator>
          <dc:creator>Weixiong Xu (25157608)</dc:creator>
          <dc:creator>Lifen Yan (1404280)</dc:creator>
          <dc:creator>ChuanMiao Xie (25157611)</dc:creator>
          <dc:creator>Changhong Liang (215520)</dc:creator>
          <dc:creator>Zaiyi Liu (611024)</dc:creator>
          <dc:creator>Tong Tong (532210)</dc:creator>
          <dc:creator>Yanfen Cui (2146873)</dc:creator>
          <dc:creator>Xin-Juan Fan (329948)</dc:creator>
          <dc:creator>Ke Zhao (248186)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Mathematical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>sup &gt;+&lt;/ sup</dc:subject>
          <dc:subject>observer variability inherent</dc:subject>
          <dc:subject>multivariable cox regression</dc:subject>
          <dc:subject>magnetic resonance imaging</dc:subject>
          <dc:subject>evaluated using kaplan</dc:subject>
          <dc:subject>dice similarity coefficient</dc:subject>
          <dc:subject>9 %, hr</dc:subject>
          <dc:subject>evaluate segmentation performance</dc:subject>
          <dc:subject>dilated vessel segmentation</dc:subject>
          <dc:subject>observer agreement analysis</dc:subject>
          <dc:subject>meier survival analysis</dc:subject>
          <dc:subject>important prognostic biomarker</dc:subject>
          <dc:subject>achieved substantial agreement</dc:subject>
          <dc:subject>significantly lower 3</dc:subject>
          <dc:subject>75 – 3</dc:subject>
          <dc:subject>reflecting tumor invasiveness</dc:subject>
          <dc:subject>intravascular tumor signal</dc:subject>
          <dc:subject>year overall survival</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>7 %– 88</dc:subject>
          <dc:subject>7 %– 85</dc:subject>
          <dc:subject>mremvi assessment based</dc:subject>
          <dc:subject>manual mremvi assessment</dc:subject>
          <dc:subject>based segmentation model</dc:subject>
          <dc:subject>1 %, hr</dc:subject>
          <dc:subject>mremvi status identified</dc:subject>
          <dc:subject>comprehensive prognostic validation</dc:subject>
          <dc:subject>713 – 0</dc:subject>
          <dc:subject>95 – 3</dc:subject>
          <dc:subject>level segmentation</dc:subject>
          <dc:subject>reader agreement</dc:subject>
          <dc:subject>prognostic value</dc:subject>
          <dc:subject>free survival</dc:subject>
          <dc:subject>year disease</dc:subject>
          <dc:subject>work establishes</dc:subject>
          <dc:subject>vs .&lt;/</dc:subject>
          <dc:subject>treatment individualization</dc:subject>
          <dc:subject>training cohort</dc:subject>
          <dc:subject>study trained</dc:subject>
          <dc:subject>senior radiologists</dc:subject>
          <dc:subject>risk stratification</dc:subject>
          <dc:subject>rectal cancer</dc:subject>
          <dc:subject>patients identified</dc:subject>
          <dc:subject>p &lt;/</dc:subject>
          <dc:subject>objective framework</dc:subject>
          <dc:subject>metastatic potential</dc:subject>
          <dc:subject>level localization</dc:subject>
          <dc:subject>internal five</dc:subject>
          <dc:subject>fold cross</dc:subject>
          <dc:description>&lt;div&gt;&lt;p&gt;MRI-detected extramural vascular invasion (mrEMVI) is an important prognostic biomarker in rectal cancer, reflecting tumor invasiveness and metastatic potential. To address the subjectivity and inter-observer variability inherent in manual mrEMVI assessment, this study trained and validated an nnUNet-based segmentation model for automated voxel-level localization and visualization of mrEMVI. This multi-center retrospective study included a total of 2,501 rectal cancer patients, comprising 1,830 in the training cohort (with 5-fold cross-validation) and 671 in two independent external test cohorts. The Dice similarity coefficient was used to evaluate segmentation performance; the inter-reader agreement for mrEMVI identification was assessed using Cohen’s kappa (κ). The prognostic value of mrEMVI status identified by the artificial intelligence (AI) model was evaluated using Kaplan-Meier survival analysis and multivariable Cox regression. In internal five-fold cross-validation, the model yielded Dice scores of 0.850, 0.442, and 0.335 for tumor, intravascular tumor signal, and dilated vessel segmentation, respectively. The model demonstrated strong classification performance, with accuracies of 81.5% (95% CI: 76.7%–85.8%) and 84.7% (95% CI: 80.7%–88.2%) in the two external test cohorts, and achieved substantial agreement with senior radiologists (κ = 0.713–0.736). Patients identified as AI-mrEMVI&lt;sup&gt;+&lt;/sup&gt; had significantly lower 3-year disease-free survival (DFS) and 5-year overall survival (OS) rates than AI-mrEMVI&lt;sup&gt;−&lt;/sup&gt; patients (DFS: 62.3% &lt;i&gt;vs.&lt;/i&gt; 84.9%, HR = 2.67, 95% CI: 1.95–3.66; OS: 68.7% &lt;i&gt;vs.&lt;/i&gt; 87.1%, HR = 2.64, 95% CI: 1.75–3.97; both &lt;i&gt;p&lt;/i&gt; &lt; 0.001). This work establishes a scalable, objective framework for mrEMVI assessment based on voxel-level segmentation, inter-observer agreement analysis, and comprehensive prognostic validation, with direct implications for risk stratification and treatment individualization in rectal cancer.&lt;/p&gt;&lt;/div&gt;</dc:description>
          <dc:date>2026-10-01T17:40:25Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pdig.0001763.t002</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Univariable_and_multivariable_analyses_of_DFS_p_/34048961</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
